Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice
Vehicle-control MIA mice that received intraventricular normal saline infusions did not have a significant change in sociability index scores, with pre-vehicle scores of 8.2 1.4 comparable to post-vehicle score of 5.2 1.7, p = 0.70 (Fig 2A)
BPC-157 focuses on healing, inflammation, and gut health
Able C, Liao B, Saffati G, et al
While semaglutide works primarily on the GLP-1 receptor, newer dual-agonist medications may offer a distinct approach for those whose weight loss has plateaued or for those seeking better control over blood sugar markers
ALTO TE MERECES UN BREAK